| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A1Z4B6 | Cytochrome b; | CYTB; | NULL | 380 | human |
| F2WH89 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| B3KVR9 | HCG2004980, isoform CRA_a; cDNA FLJ41235 fis, clone BRAMY2031317, highly similar to PDZ domain-containing protein 4; | NULL | NULL | 673 | human |
| A8DIL7 | Cytochrome b; | CYTB; | NULL | 380 | human |
| X2CVF3 | AKT1m transcript variant 1; AKT1m transcript variant 2; AKT1m transcript variant 4; Fragment; | AKT1; | NULL | 38 | human |
| H9PB80 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| K7EIT1 | Solute carrier family 2, facilitated glucose transporter member 5; Fragment; | SLC2A5; | NULL | 190 | human |
| H9RBV5 | Cytochrome b; | CYTB; | NULL | 380 | human |
| A0A059S383 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| C9JZS0 | Amyotrophic lateral sclerosis 2 (Juvenile) chromosome region, candidate 12, isoform CRA_b; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein; Fragment; | ALS2CR12; | NULL | 143 | human |
| H9Q3H1 | Cytochrome b; | CYTB; | NULL | 380 | human |
| E5DY33 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| B2XL11 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| Q8N4M4 | FERM domain-containing protein 8; FRMD8 protein; | FRMD8; | NULL | 66 | human |
| I3L0A0 | HCG2044781; Protein TMEM189-UBE2V1; | TMEM189-UBE2V1; | NULL | 370 | human |
| F5H8B4 | Histone demethylase UTY; | UTY; | NULL | 1444 | human |
| Q1XBU8 | Cell proliferation-inducing protein 23; Protein inhibitor of activated STAT, 1, isoform CRA_b; | PIAS1; | XP_005254792.1; | 642 | human |
| D6RA65 | SH3 domain and tetratricopeptide repeat-containing protein 2; | SH3TC2; | NULL | 227 | human |
| K7EMR7 | Reticulon; | RTN2; | NULL | 271 | human |
| Q9HCU2 | Poly(RC) binding protein 4, isoform CRA_d; RNA binding protein MCG10; | PCBP4; | NULL | 369 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |